Kathryn E. Ware

2.0k total citations
27 papers, 1.5k citations indexed

About

Kathryn E. Ware is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Kathryn E. Ware has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Kathryn E. Ware's work include Cancer Genomics and Diagnostics (9 papers), Prostate Cancer Treatment and Research (7 papers) and Fibroblast Growth Factor Research (5 papers). Kathryn E. Ware is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Prostate Cancer Treatment and Research (7 papers) and Fibroblast Growth Factor Research (5 papers). Kathryn E. Ware collaborates with scholars based in United States, India and United Kingdom. Kathryn E. Ware's co-authors include Jason A. Somarelli, Mohit Kumar Jolly, Herbert Levine, Shivee Gilja, Lynn E. Heasley, Lindsay A. Marek, Andrew J. Armstrong, Mariano A. García-Blanco, Barbara A. Helfrich and Trista K. Hinz and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Kathryn E. Ware

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn E. Ware United States	16	870	548	513	399	171	27	1.5k
Janna Paulsson Sweden	19	748 0.9×	703 1.3×	292 0.6×	398 1.0×	217 1.3×	21	1.5k
Joshua Armenia United States	18	841 1.0×	680 1.2×	412 0.8×	512 1.3×	153 0.9×	35	1.6k
Pamela Villalobos United States	18	598 0.7×	621 1.1×	350 0.7×	329 0.8×	161 0.9×	27	1.3k
Miguel Quintela-Fandiño Spain	21	653 0.8×	452 0.8×	223 0.4×	432 1.1×	176 1.0×	64	1.2k
David Balli United States	16	764 0.9×	826 1.5×	464 0.9×	360 0.9×	264 1.5×	31	1.6k
Nikolina Radulovich Canada	22	910 1.0×	748 1.4×	232 0.5×	415 1.0×	141 0.8×	36	1.6k
Mariam Jamal‐Hanjani United Kingdom	18	447 0.5×	488 0.9×	386 0.8×	424 1.1×	158 0.9×	42	1.1k
Ian A.J. Lorimer Canada	21	710 0.8×	518 0.9×	308 0.6×	399 1.0×	106 0.6×	41	1.3k
Colin R. Lindsay United Kingdom	20	580 0.7×	714 1.3×	465 0.9×	398 1.0×	78 0.5×	68	1.4k
Atish D. Choudhury United States	16	892 1.0×	568 1.0×	654 1.3×	472 1.2×	74 0.4×	79	1.7k

Countries citing papers authored by Kathryn E. Ware

Since Specialization

Citations

This map shows the geographic impact of Kathryn E. Ware's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Ware with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Ware more than expected).

Fields of papers citing papers by Kathryn E. Ware

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Ware. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Ware. The network helps show where Kathryn E. Ware may publish in the future.

Co-authorship network of co-authors of Kathryn E. Ware

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn E. Ware. A scholar is included among the top collaborators of Kathryn E. Ware based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn E. Ware. Kathryn E. Ware is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pillai, Maalavika, et al.. (2023). Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer. Computational and Structural Biotechnology Journal. 21. 1498–1509. 5 indexed citations

Ware, Kathryn E., Beatrice C. Thomas, Maya U. Sheth, et al.. (2023). A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer. Frontiers in Molecular Biosciences. 10. 1104505–1104505. 6 indexed citations

Palencia-Madrid, Leire, Marian M. de Pancorbo, Javier Rodríguez Luis, et al.. (2022). Post-Austronesian migrational wave of West Polynesians to Micronesia. Gene. 823. 146357–146357. 1 indexed citations

Ware, Kathryn E., Nicolas Devos, David L. Corcoran, et al.. (2022). Exome sequencing of hepatocellular carcinoma in lemurs identifies potential cancer drivers. Evolution Medicine and Public Health. 10(1). 221–230.

Blawas, Ashley M., Kathryn E. Ware, Nicolas Devos, et al.. (2021). An integrated comparative physiology and molecular approach pinpoints mediators of breath-hold capacity in dolphins. Evolution Medicine and Public Health. 9(1). 420–430. 5 indexed citations

Zhang, Tian, Anika Agarwal, Rengasamy Boominathan, et al.. (2021). Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer. Biomarker Research. 9(1). 14–14. 31 indexed citations

Somarelli, Jason A., Gabrielle Rupprecht, Sneha Rao, et al.. (2020). A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma. Cancers. 12(11). 3335–3335. 13 indexed citations

Somarelli, Jason A., Ali Sanjari Moghaddam, Beatrice C. Thomas, et al.. (2020). A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer. Molecular Cancer Therapeutics. 19(12). 2516–2527. 25 indexed citations

Chen, Kai‐Yuan, So Young Kim, Shannon J. McCall, et al.. (2020). Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer. BMC Cancer. 20(1). 592–592. 14 indexed citations

10.

Rao, Sneha, Jason A. Somarelli, Laura E. Selmic, et al.. (2020). From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision Medicine. Frontiers in Oncology. 10. 117–117. 16 indexed citations

11.

Vaishnavi, Aria, Laura Schubert, Uwe Rix, et al.. (2017). EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases. Cancer Research. 77(13). 3551–3563. 61 indexed citations

12.

Ware, Kathryn E., Shivee Gilja, Mohit Kumar Jolly, et al.. (2017). Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells. Journal of Visualized Experiments. 7 indexed citations

13.

Jolly, Mohit Kumar, Kathryn E. Ware, Shivee Gilja, Jason A. Somarelli, & Herbert Levine. (2017). EMT and MET : necessary or permissive for metastasis?. Molecular Oncology. 11(7). 755–769. 282 indexed citations

14.

Gupta, Santosh, Jing Li, Gabor Kemeny, et al.. (2016). Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 23(5). 1346–1357. 52 indexed citations

15.

Somarelli, Jason A., Kathryn E. Ware, Rumen Kostadinov, et al.. (2016). PhyloOncology: Understanding cancer through phylogenetic analysis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1867(2). 101–108. 24 indexed citations

16.

Wynes, Murry W., Trista K. Hinz, Dexiang Gao, et al.. (2014). FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies. Clinical Cancer Research. 20(12). 3299–3309. 125 indexed citations

17.

Hinz, Trista K., Scott A. Kono, Katherine R. Singleton, et al.. (2011). Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells. Clinical Cancer Research. 17(15). 5016–5025. 84 indexed citations

18.

Keating, Amy K., Andrew M. Donson, Kathryn E. Ware, et al.. (2010). Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity. Molecular Cancer Therapeutics. 9(5). 1298–1307. 120 indexed citations

19.

Kono, Scott A., et al.. (2009). The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer. Drug Resistance Updates. 12(4-5). 95–102. 57 indexed citations

20.

Marek, Lindsay A., Kathryn E. Ware, Jennifer E. Smith, et al.. (2008). Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells. Molecular Pharmacology. 75(1). 196–207. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact